Page last updated: 2024-08-22

chloropyramine and Melanoma

chloropyramine has been researched along with Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bshara, W; Cance, WG; Gogate, P; Hochwald, SN; Kurenova, E; Liao, J; Seshadri, M; Sunar, U; Ucar, D; Yemma, M	1

Other Studies

1 other study(ies) available for chloropyramine and Melanoma

Article	Year
A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cells. Cell cycle (Georgetown, Tex.), 2014, Volume: 13, Issue:16 Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Inhibitors; Ethylenediamines; Focal Adhesion Protein-Tyrosine Kinases; Heterografts; Human Umbilical Vein Endothelial Cells; Humans; Melanoma; Mice; Protein Multimerization; Proto-Oncogene Proteins B-raf; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2	2014

Article

Year

A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cells.

Cell cycle (Georgetown, Tex.), 2014, Volume: 13, Issue:16

Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Inhibitors; Ethylenediamines; Focal Adhesion Protein-Tyrosine Kinases; Heterografts; Human Umbilical Vein Endothelial Cells; Humans; Melanoma; Mice; Protein Multimerization; Proto-Oncogene Proteins B-raf; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2

2014